Are the Direct Oral Anticoagulants Better for Patients with Low Time in the Therapeutic Range on Vitamin K Antagonist Therapy?

Thromb Haemost. 2024 Aug;124(8):791-794. doi: 10.1055/s-0044-1787299. Epub 2024 Jun 1.

Authors

Jordan K Schaefer¹, Geoffrey D Barnes²

Affiliations

¹ Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States.
² Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States.

PMID: 38823378
DOI: 10.1055/s-0044-1787299

No abstract available

Publication types

Letter
Comment

MeSH terms

Administration, Oral
Anticoagulants* / administration & dosage
Anticoagulants* / adverse effects
Anticoagulants* / therapeutic use
Blood Coagulation / drug effects
Hemorrhage / chemically induced
Humans
Time Factors
Vitamin K* / antagonists & inhibitors

Substances

Vitamin K
Anticoagulants